Search
01/11/2024
A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy
Cheng, AYY, Mauricio, D, Ritzel, R, Al-Sofiani, ME, Bailey, T, Mabunay, MA, Bonnemaire, M, Melas-Melt, L, Mimouni, S, Davies, M. A post-hoc pooled analysis to evaluate efficacy and safety of insulin glargine 300 U/mL in insulin-naïve people with type 2 diabetes with/ without prior use of glucagon-like peptide-1 receptor agonist therapy. DIABETES RESEARCH AND CLINICAL PRACTICE. 2024; 217DOI:10.1016/j.diabres.2024.111871. PMID:39343145. IF:7.400(Q1/1D).
01/11/2024
Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU
Casanova, MJ, Caballol, B, García, MJ, Mesonero, F, de Célix, CR, Suárez-Alvarez, P, Ferreiro-Iglesias, R, Martín-Rodríguez, MDM, de Francisco, R, Varela-Trastoy, P, Bastida, G, Carrillo-Palau, M, Núñez-Ortiz, A, Ramírez-de la Piscina, P, Ceballos, D, Hervías-Cruz, D, Muñoz-Pérez, R, Velayos, B, Bermejo, F, Busquets, D, Cabacino, M, Camo-Monterde, P, Marín-Jiménez, I, Muñoz, C, de la Peña-Negro, LC, Sierra-Moros, E, Barrio, J, Brunet-Mas, E, Bujanda, L, Cañete, F, Gomollón, F, Manceñido-Marcos, N, Rodríguez-Lago, I, Rodríguez-Grau, MC, Sicilia, B, Torra-Alsina, S, Arranz-Hernández, L, Carpio, D, García-Sepulcre, MF, González-Muñoza, C, Huguet, JM, Márquez-Mosquera, L, López-Serrano, MP, Ponferrada-Díaz, A, Chaparro, M, Gisbert, JP. Persistence, effectiveness and safety of ustekinumab and vedolizumab therapy for complex perianal fistula in Crohn's disease: The HEAL study from GETECCU. DIGESTIVE AND LIVER DISEASE. 2024; 56(11)DOI:10.1016/j.dld.2024.05.009. PMID:38839456. IF:3.800(Q2/3D).
01/11/2024
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA
Gargallo-Puyuelo, CJ, Ricart, E, Iglesias, E, de Francisco, R, Gisbert, JP, Taxonera, C, Mañosa, M, Peris, MA, Navarrete-Muñoz, EM, Sanahuja, A, Guardiola, J, Mesonero, F, Tirado, MR, Barrio, J, Mendoza, IV, Parga, LD, García-Planella, E, Calvet, X, Arranz, MDM, García, S, Sicilia, B, Carpio, D, Domenech, E, Gomollón, F. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA. Clinical Gastroenterology and Hepatology. 2024; 22(11)DOI:10.1016/j.cgh.2024.05.013. PMID:38782172. IF:12.000(Q1/1D).
01/11/2024
Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis
Martín-Gutiérrez, A, Loricera, J, Narváez, J, Aldasoro, V, Maiz, O, Vela, P, Romero-Yuste, S, de Miguel, E, Galíndez-Agirregoikoa, E, Fernández-López, JC, Ferraz-Amaro, I, Sánchez-Martín, J, Moya, P, Campos, C, Lopez-Gutierrez, F, Castaneda, S, Blanco, R. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis. European Journal of Internal Medicine. 2024; 129DOI:10.1016/j.ejim.2024.06.013. PMID:38908981. IF:6.100(Q1/1D).